Asymptomatic Pancreatic Cystic Neoplasms: Maximizing Survival and Quality of Life Using Markov-Based Clinical Nomograms

Gastroenterology

Volumn 138, Issue 2, 2010, Pages 531-540

  Weinberg, Benjamin M ^a,b   Spiegel, Brennan M R ^a,b,c,d   Tomlinson, James S ^a,b   Farrell, James J ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURVIVAL; CASE MANAGEMENT; CLINICAL DECISION MAKING; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; EVIDENCE BASED PRACTICE; HUMAN; NOMOGRAM; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CYST; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL; SYSTEMATIC REVIEW; TUMOR VOLUME;

EID: 75149186092     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.10.001     Document Type: Article

References (79)

1. Spinelli K.S., Fromwiller T.E., Daniel R.A., et al. Cystic pancreatic neoplasms: observe or operate. Ann Surg 239 (2004) 651-657
2. Sohn T.A., Yeo C.J., Cameron J.L., et al. IPMN of the pancreas: an updated experience. Ann Surg 239 (2004) 788-797
3. Tran K.T., Smeenk H.G., van Eijck C.H., et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240 (2004) 738-745
4. Yeo C.J., Abrams R.A., Grochow L.B., et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg 225 (1997) 621-633
5. Goh B.K., Tan Y.M., Cheow P.C., et al. Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years. Am J Surg 192 (2006) 148-154
6. Tang R.S., Weinberg B., Dawson D.W., et al. Evaluation of the guidelines for management of pancreatic branch-duct IPMN. Clin Gastroenterol Hepatol 6 (2008) 815-819
7. Kloppel G.S., and Longnecker E. Histological typing of tumors of the exocrine pancreas. World Health Organization: international histological classification of tumors (1996), Springer-Verlag, Berlin, Germany
8. Seiler C.A., Wagner M., Bachmann T., et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92 (2005) 547-556
9. Irie H., Yoshimitsu K., Aibe H., et al. Natural history of pancreatic IPMT of branch duct type: follow-up study by MRCP. J Comput Assist Tomogr 28 (2004) 117-122
10. Kawamoto S., Horton K.M., Lawler L.P., et al. IPMN of the pancreas: can benign lesions be differentiated from malignant lesions with multidetector CT?. Radiographics 25 (2005) 1451-1468
11. Terris B., Ponsot P., Paye F., et al. IPMT of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 24 (2000) 1372-1377
12. Tanaka M., Chari S., Adsay V., et al. International consensus guidelines for management of IPMN and mucinous cystic neoplasms of the pancreas. Pancreatology 6 (2006) 17-32
13. Yamaguchi K., Ogawa Y., Chijiiwa K., et al. Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg 171 (1996) 427-431
14. Kubo H., Chijiiwa Y., Akahoshi K., et al. IPMT of the pancreas: differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. Am J Gastroenterol 96 (2001) 1429-1434
15. Matsumoto T., Aramaki M., Yada K., et al. Optimal management of the branch duct type IPMN of the pancreas. J Clin Gastroenterol 36 (2003) 261-265
16. Kobari M., Egawa S., Shibuya K., et al. IPMT of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 134 (1999) 1131-1136
17. Doi R., Fujimoto K., Wada M., et al. Surgical management of IPMT of the pancreas. Surgery 132 (2002) 80-85
18. Kitagawa Y., Unger T.A., Taylor S., et al. Mucus is a predictor of better prognosis and survival in patients with IPMT of the pancreas. J Gastrointest Surg 7 (2003) 12-18
19. Chari S.T., Yadav D., Smyrk T.C., et al. Study of recurrence after surgical resection of IPMN of the pancreas. Gastroenterology 123 (2002) 1500-1507
20. Yamaguchi T., Baba T., Ishihara T., et al. Long-term follow-up of IPMN of the pancreas with ultrasonography. Clin Gastroenterol Hepatol 3 (2005) 1136-1143
21. Chaudhari V.V., Raman S.S., Vuong N.L., et al. Pancreatic cystic lesions: discrimination accuracy based on clinical data and high resolution CT features. J Comput Assist Tomogr 31 (2007) 860-867
22. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 126 (2004) 1330-1336
23. Kawamoto S., Lawler L.P., Horton K.M., et al. MDCT of IPMN of the pancreas: evaluation of features predictive of invasive carcinoma. AJR Am J Roentgenol 186 (2006) 687-695
24. Procacci C., Carbognin G., Biasiutti C., et al. IPMT of the pancreas: spectrum of CT and MR findings with pathologic correlation. Eur Radiol 11 (2001) 1939-1951
25. Cellier C., Cuillerier E., Palazzo L., et al. IPMT of the pancreas: accuracy of preoperative computed tomography, ERCP and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc 47 (1998) 42-49
26. Sugiyama M., and Atomi Y. IPMT of the pancreas: imaging studies and treatment strategies. Ann Surg 228 (1998) 685-691
27. Rodriguez J.R., Salvia R., Crippa S., et al. Branch-duct IPMN: observations in 145 patients who underwent resection. Gastroenterology 133 (2007) 72-79
28. Raimondo M., Tachibana I., Urrutia R., et al. Invasive cancer and survival of IPMT of the pancreas. Am J Gastroenterol 97 (2002) 2553-2558
29. Salvia R., Fernandez-del Castillo C., Bassi C., et al. Main-duct IPMN of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239 (2004) 678-685
30. Spiegel B.M., Targownik L.E., Kanwal F., et al. The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal. Gastroenterology 127 (2004) 403-411
31. Suzuki Y., Atomi Y., Sugiyama M., et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of IPMT and mucinous cystic tumor. Pancreas 28 (2004) 241-246
32. Schmier J., Elixhauser A., and Halpern M.T. Health-related quality of life evaluations of gastric and pancreatic cancer. Hepatogastroenterology 46 (1999) 1998-2004
33. Park S.M., Park M.H., Won J.H., et al. EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care units. Support Care Cancer 14 (2006) 329-333
34. Behrman S.W., and Mulloy M. Total pancreatectomy for the treatment of chronic pancreatitis: indications, outcomes, and recommendations. Am Surg 72 (2006) 297-302
35. McLeod R.S., Taylor B.R., O'Connor B.I., et al. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 169 (1995) 179-185
36. Billings B.J., Christein J.D., Harmsen W.S., et al. Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?. J Gastrointest Surg 9 (2005) 1059-1066
37. Scheingraber S., Scheingraber T., Brauckhoff M., et al. Comparison between a general and a disease-specific health-related quality-of-life questionnaire in patients after pancreatic surgery. J Hepatobiliary Pancreat Surg 12 (2005) 290-297
38. Lidgren M., Wilking N., Jonsson B., et al. Health related quality of life in different states of breast cancer. Qual Life Res 16 (2007) 1073-1081
39. Jang J.Y., Kim S.W., Lee S.E., et al. Treatment guidelines for branch duct type IPMN of the pancreas: when can we operate or observe?. Ann Surg Oncol 15 (2008) 199-205
40. Hammel P.P., and Palazzo P. Frequency of lesions leading to erroneous diagnosis of IPMT of the pancreas. Gastroenterology 132 (2007) A-761
41. Schmidt C.M., White P.B., Waters J.A., et al. IPMN: predictors of malignant and invasive pathology. Ann Surg 246 (2007) 644-651
42. Jang J.Y., Kim S.W., Ahn Y.J., et al. Multicenter analysis of clinicopathologic features of IPMT of the pancreas: is it possible to predict the malignancy before surgery?. Ann Surg Oncol 12 (2005) 124-132
43. Tada M., Kawabe T., Arizumi M., et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol 4 (2006) 1265-1270
44. Zamora C., Sahel J., Cantu D.G., et al. IPMT of the pancreas: report of a case series and review of the literature. Am J Gastroenterol 96 (2001) 1441-1447
45. Sugiyama M., Izumisato Y., Abe N., et al. Predictive factors for malignancy in IPMT of the pancreas. Br J Surg 90 (2003) 1244-1249
46. Salvia R., Crippa S., Falconi M., et al. Branch-duct IPMN of the pancreas: to operate or not to operate?. Gut 56 (2007) 1086-1090
47. Pelaez-Luna M., Chari S.T., Smyrk T.C., et al. Do consensus indications for resection in branch duct IPMN predict malignancy?. A study of 147 patients. Am J Gastroenterol 102 (2007) 1759-1764
48. Levy P., Jouannaud V., O'Toole D., et al. Natural history of IPMT of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol 4 (2006) 460-468
49. Kobayashi G., Fujita N., Noda Y., et al. Mode of progression of IPMT of the pancreas: analysis of patients with follow-up by EUS. J Gastroenterol 40 (2005) 744-751
50. Tseng J.F., Warshaw A.L., Sahani D.V., et al. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 242 (2005) 413-419
51. D'Angelica M., Brennan M.F., Suriawinata A.A., et al. IPMN of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 239 (2004) 400-408
52. Diener M.K., Knaebel H.P., Heukaufer C., et al. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 245 (2007) 187-200
53. Wade T.P., el-Ghazzawy A.G., Virgo K.S., et al. The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospitals. Ann Surg 221 (1995) 241-248
54. Imaizumi T., Hanyu F., Harada N., et al. Extended radical Whipple resection for cancer of the pancreatic head: operative procedure and results. Dig Surg 15 (1998) 299-307
55. Schafer M., Mullhaupt B., and Clavien P.A. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 236 (2002) 137-148
56. Yeo C.J., Cameron J.L., Sohn T.A., et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226 (1997) 248-257
57. Maire F., Hammel P., Terris B., et al. Prognosis of malignant IPMT of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 51 (2002) 717-722
58. Wada K., Kozarek R.A., and Traverso L.W. Outcomes following resection of invasive and noninvasive IPMN of the pancreas. Am J Surg 189 (2005) 632-636
59. Lin P.W., and Lin Y.J. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 86 (1999) 603-607
60. Benassai G., Mastrorilli M., Quarto G., et al. Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Chir Ital 52 (2000) 263-270
61. Geer R.J., and Brennan M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165 (1993) 68-72
62. Millikan K.W., Deziel D.J., Silverstein J.C., et al. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 65 (1999) 618-623
63. Tsao J.I., Rossi R.L., and Lowell J.A. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation. Arch Surg 129 (1994) 405-412
64. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221 (1995) 721-731
65. Stocken D.D., Buchler M.W., Dervenis C., et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92 (2005) 1372-1381
66. Oettle H., Post S., Neuhaus P., et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297 (2007) 267-277
67. Neoptolemos J.P., Dunn J.A., Stocken D.D., et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358 (2001) 1576-1585
68. Glimelius B., Hoffman K., Sjoden P.O., et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7 (1996) 593-600
69. Eloubeidi M.A., Gress F.G., Savides T.J., et al. Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States. Gastrointest Endosc 60 (2004) 385-389
70. Eloubeidi M.A., Chen V.K., Eltoum I.A., et al. EUS guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 98 (2003) 2663-2668
71. Bournet B., Migueres I., Delacroix M., et al. Early morbidity of EUS: 13 years' experience at a referral center. Endoscopy 38 (2006) 349-354
72. O'Toole D., Palazzo L., Arotcarena R., et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc 53 (2001) 470-474
73. Cuillerier E., Cellier C., Palazzo L., et al. Outcome after surgical resection of IPMT and mucinous tumors of the pancreas. Am J Gastroenterol 95 (2000) 441-445
74. Conlon K.C., Klimstra D.S., and Brennan M.F. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223 (1996) 273-279
75. White R., D'Angelica M., Katabi N., et al. Fate of the remnant pancreas after resection of noninvasive IPMN. J Am Coll Surg 204 (2007) 987-993
76. Taouli B., Vilgrain V., Vullierme M.P., et al. IPMT of the pancreas: helical CT with histopathologic correlation. Radiology 217 (2000) 757-764
77. Soweid A., Azar C., and Labban B. Endosonographic evaluation of IPMT of the pancreas. JOP 5 (2004) 258-265
78. Mackenzie R., Hollingworth W., and Dixon A.K. Quality of life assessments in the evaluation of magnetic resonance imaging. Qual Life Res 3 (1994) 29-37
79. Nguyen T.C., Sohn T.A., Cameron J.L., et al. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 7 (2003) 1-8